Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. 

Biotechnology

CIRCULOGENE

Mike Mullen

Christy Lee

Paul R. Walker

Louis Apicella (Lou)

Scott Grissett

Eric Thompson

J. Kevin Day

Jessica Absher

Lou Apicella

Travis Wold

Jonice Vanterpool Johnson

Anthony L. Schmidt

Chen-Hsiung Yeh

The board of directors at CIRCULOGENE has a history of experience with companies such as TwiXimo Therapeutics, Inc., Glympse Bio, and BIOLASE, Inc. They also have experience in advising companies such as Go Forward Health. The board members have educational backgrounds in fields such as chemistry from Stanford University.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at CIRCULOGENE

Leadership Team

CEO and Executive Team